Table 3.
Phenotype | Clinical Featuresa | CTG Repeat Length |
---|---|---|
Normal (unaffected) | None | 5–34 |
| ||
Premutation | None | 35–49 |
| ||
Mild | Cataracts | 50–150 |
Mild myotonia | ||
| ||
Classic | Weakness | 100–1000 |
Myotonia | ||
Cataracts | ||
Cardiac arrhythmia | ||
| ||
Congenital | Infantile hypotonia | >1000 |
Respiratory difficulties | ||
Intellectual disability |
There is significant overlap of phenotypes and CTG repeats, making predictions of age of onset and severity for individual patients challenging.
Data from The International Myotonic Dystrophy Consortium (IDMC). New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 2000;54(6):1218–1221.